Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):246–253. doi: 10.1097/QAI.0000000000000312

Figure 2.

Figure 2

Kaplan-Meier curve of time to virologic failure between those with presumed transmitted drug resistance (TDR) detected in codons M184V, K103N, Y181C, and/or G190A by oligonucleotide ligation assay (OLA) (dashed line) and those without TDR by OLA (solid line).

Note: The number of participants at risk at each time point is listed and the number experiencing virologic failure is in parentheses.